Collagen Peptides: Regulatory Status
Current legal and regulatory status for Collagen Peptides across jurisdictions. This page reflects the most recent verified information and is updated as regulatory actions occur.
Back to Collagen Peptides overviewUnited States
Compoundable (503A)
Prescription required
Compounding status: not applicable (dietary supplement/food ingredient). WADA: not listed. sold globally as dietary supplement; multi-billion dollar market; EU novel food status for marine collagen
What This Means
Compoundable does not mean FDA approved.
Collagen Peptides is available through licensed 503A compounding pharmacies with a physician's prescription. This is a regulatory pathway, not an endorsement of efficacy for any specific indication. All use is off-label.
Reclassification is not the same as FDA approval.
Even if Collagen Peptides moves to Category 1, it remains an off-label therapeutic that requires physician supervision. Category 1 means it can be compounded under section 503A — it does not confer approved-drug status.